202 related articles for article (PubMed ID: 30339906)
21. One-pot synthesis and characterization of ovalbumin-conjugated gold nanoparticles: A comparative study of adjuvanticity against the physical mixture of ovalbumin and gold nanoparticles.
Yang Y; Zhang Y; Thakur A; Li R; Xu H; Wang Z; Ghavami M; Tu Z; Liu H
Int J Pharm; 2019 Nov; 571():118704. PubMed ID: 31536763
[TBL] [Abstract][Full Text] [Related]
22. Mucosal Vaccination With Recombinant
Wei J; Hegde VL; Yanamandra AV; O'Hara MP; Keegan B; Jones KM; Strych U; Bottazzi ME; Zhan B; Sastry KJ; Hotez PJ
Front Immunol; 2022; 13():800295. PubMed ID: 35197976
[TBL] [Abstract][Full Text] [Related]
23. Antigen-conjugated N-trimethylaminoethylmethacrylate chitosan nanoparticles induce strong immune responses after nasal administration.
Liu Q; Zheng X; Zhang C; Shao X; Zhang X; Zhang Q; Jiang X
Pharm Res; 2015 Jan; 32(1):22-36. PubMed ID: 24970313
[TBL] [Abstract][Full Text] [Related]
24. Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice.
Sasaki H; Ishikawa H; Kojima K; Itoh M; Matsumoto T; Itoh T; Hosomi O; Kawamoto E
Vaccine; 2013 Nov; 31(48):5729-35. PubMed ID: 24091313
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and Toxicity of Different Adjuvants Can Be Characterized by Profiling Lung Biomarker Genes After Nasal Immunization.
Sasaki E; Asanuma H; Momose H; Furuhata K; Mizukami T; Hamaguchi I
Front Immunol; 2020; 11():2171. PubMed ID: 33013912
[TBL] [Abstract][Full Text] [Related]
26. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
27. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
28. Development of (Inhalable) Dry Powder Formulations of AS01
AboulFotouh K; Xu H; Moon C; Williams RO; Cui Z
Int J Pharm; 2022 Jun; 622():121825. PubMed ID: 35577037
[TBL] [Abstract][Full Text] [Related]
29. Preparation and evaluation of antigen/N-trimethylaminoethylmethacrylate chitosan conjugates for nasal immunization.
Liu Q; Zhang C; Zheng X; Shao X; Zhang X; Zhang Q; Jiang X
Vaccine; 2014 May; 32(22):2582-90. PubMed ID: 24681230
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques.
Veazey RS; Siddiqui A; Klein K; Buffa V; Fischetti L; Doyle-Meyers L; King DF; Tregoning JS; Shattock RJ
Hum Vaccin Immunother; 2015; 11(12):2913-22. PubMed ID: 26697975
[TBL] [Abstract][Full Text] [Related]
31. Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine.
Clausi AL; Morin A; Carpenter JF; Randolph TW
J Pharm Sci; 2009 Jan; 98(1):114-21. PubMed ID: 18506831
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Systemic and Mucosal Immune Responses Induced by a Nasal Powder Delivery System in Conjunction with an OVA Antigen in Cynomolgus Monkeys.
Torikai Y; Sasaki Y; Sasaki K; Kyuno A; Haruta S; Tanimoto A
J Pharm Sci; 2021 May; 110(5):2038-2046. PubMed ID: 33278410
[TBL] [Abstract][Full Text] [Related]
33. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.
Amorij JP; Saluja V; Petersen AH; Hinrichs WL; Huckriede A; Frijlink HW
Vaccine; 2007 Dec; 25(52):8707-17. PubMed ID: 17996993
[TBL] [Abstract][Full Text] [Related]
35. Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles.
Li X; Aldayel AM; Cui Z
J Control Release; 2014 Jan; 173():148-57. PubMed ID: 24188959
[TBL] [Abstract][Full Text] [Related]
36. Structural characterization of archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) formulations prepared by different protocols and their efficacy upon intranasal immunization of mice.
Patel GB; Ponce A; Zhou H; Chen W
J Liposome Res; 2008; 18(2):127-43. PubMed ID: 18569448
[TBL] [Abstract][Full Text] [Related]
37. Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens.
Canelli E; Ferrari L; Borghetti P; Candela F; Abiakam NS; Bianchera A; Buttini F; Magi GE; Sonvico F; Martelli P; Bettini R
Front Vet Sci; 2023; 10():1116722. PubMed ID: 36998637
[TBL] [Abstract][Full Text] [Related]
38. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.
Cristillo AD; Ferrari MG; Hudacik L; Lewis B; Galmin L; Bowen B; Thompson D; Petrovsky N; Markham P; Pal R
J Gen Virol; 2011 Jan; 92(Pt 1):128-40. PubMed ID: 21169215
[TBL] [Abstract][Full Text] [Related]
39. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
[TBL] [Abstract][Full Text] [Related]
40. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.
Hvalbye BK; Aaberge IS; Løvik M; Haneberg B
Infect Immun; 1999 Sep; 67(9):4320-5. PubMed ID: 10456869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
